Hi Jdmoney. Sorry for the late reply. Been on the tools at work. I'm a big believer that successful companies build ecosystems that are beneficial to all parties. Race has licensed IP concerning FTO from COH. Therefore a potential incredibly valuable income stream for COH is linked to the success of Race getting Bisantrene to market or, most probably, snapped up by BP. There is huge upside to COH if they open recruitment pathways to AML trials to Race. COH, as you know, is one of the blue ribbon cancer research entities in the world. It is in their interest to assist Race trial recruitment in AML trials as it may validate their own FTO IP. Money talks. Anyway, that's my thinking. Thanks for the enquiry. Cheers. Onward.
Hi Jdmoney. Sorry for the late reply. Been on the tools at work....
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |